- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for idix
6 Biotechnology Stocks to Buy Now
The grades of six biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong…
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS
Healthcare stocks declined 0.3% on Wall Street on Wednesday. NASDAQ:HZNP, NASDAQ:MNKD, NYSE:BSX, NASDAQ:ISIS, NYSE:COV, NYSE:EW, NASDAQ:WOOF, NYSE:CYH, NYSE:MD, NASDAQ:HMSY, NASDAQ:MYGN, NASDAQ:NPSP, NYSE:COO, NYSE:TEVA, NASDAQ:ARIA, NYSE:WST,…
6 Biotechnology Stocks to Buy Now
The grades of six biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong…
6 Biotechnology Stocks to Buy Now
The grades of six biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…
Biotech Movers: Analyst Upgrades Lift Puma
Shares of Puma, Array and Cadence rose in the wake of analyst upgrades, while Ariad and Idenix suffered setbacks.
Biggest Movers in Healthcare Stocks Now – ACHC PRXL HLS GB
Healthcare stocks remained flat on Tuesday morning on Wall Street.
Hottest Healthcare Stocks Now – ALNY SGEN PBYI RDY
Healthcare stocks fell on Wall Street so far on Wednesday, down 0.4%.
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN
Healthcare stocks remained flat so far on Wednesday on Wall Street.
Shipping Stocks Sinking to New Lows
Shipping stocks Excel Martime Carrier NYSE:EXM and Nordic American Tankers Limited NYSE:NAT are sinking to 52-week stock lows.
MannKind (MNKD) Stock Soars on Sanofi Afrezza Inhaled Insulin Deal
MannKind stock soared 7% as of Monday afternoon following news of a $925 million deal with Sanofi for its inhaled insulin drug Afrezza.
Biotech Movers: Dendreon Pops, ArQule Drops
An analyst upgrade on DNDN lifted the shares 21% last Friday, but mid-stage trial failure of a colorectal drug sank ARQL 11% the same day.
Biotech Movers: Acadia Rockets on Trial News
Acadia Pharmaceuticals leads the way with a week of eye-popping gains. Plus: Why Exelixis and Supernus took tough tumbles.
Stocks at New Highs, New Lows for 11/13
Get the scoop on today’s big moves. See which stock hit a new 52-week high, and one that found a new 52-week low.
BAC, Financials Lead Markets to Gains — Tuesday’s IP Market Recap
Stocks closed at a six-month high. Even Kodak saw a bounce.
Merck Is Shopping for Smarts In Hep C
The pharma giant says it’s determined to be the leader in treatments for the disease — a market that is expected to hit $20 billion…
Hepatitis C Drug Progress Puts Several Companies on Acquisition Watch
With their hepatitis C drugs showing promise in trials, these drug makers have become attractive targets for bigger pharma players.
Idenix and Achillion Jump on Takeover Talk
Their hepatitis C drugs could be lures for Big Pharma after a rival gets a juicy offer from Bristol-Myers Squibb.
Gilead’s Giant Gamble in Buying Pharmasset
The $11B price tag raises the stakes big-time, and critics say Gilead is overpaying to get Pharmasset’s promising hepatitis C treatment.
Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy?
Bitcoin has exploded higher over the past month setting an all-time record. That’s excellent news for Coinbase Global and COIN stock.
4 Ways to Play the Boom in Biotech Stocks
Whether you love risk or hate it, there’s a way to invest in red-hot biotech stocks. Here are four options for investors of all different…
Top 10 Dow Dividend Stocks for June
Looking for yield as we begin the second half? Look no further than these top 10 Dow dividend stocks.
Ideanomics Is the Jackson Pollock of Clean Energy
Ideanomics is throwing together a hodgepodge of clean energy and fintech bets. That doesn’t make IDEX stock a buy. Here’s why.
2 – 10 of 240 results
